We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

99 hedge funds and large institutions have $81.7M invested in 9 Meters Biopharma in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 14

36% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 25

10% more funds holding

Funds holding: 90 → 99 (+9)

8% less capital invested

Capital invested by funds: $88.6M → $81.7M (-$6.91M)

15% less call options, than puts

Call options by funds: $2.56M | Put options by funds: $3M

Holders
99
Holders Change
+9
Holders Change %
+10%
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
31
Reduced
14
Closed
25
Calls
$2.56M
Puts
$3M
Net Calls
-$438K
Net Calls Change
+$185K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$11.9M
2
Deutsche Bank
Deutsche Bank
Germany
+$3.73M
3
State Street
State Street
Massachusetts
+$3.65M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.53M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.38M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$21.1M
2
TLP
Tri Locum Partners
New York
-$7.77M
3
CH
CVI Holdings
Delaware
-$2.5M
4
MWNA
Marshall Wace North America
New York
-$1.73M
5
Citigroup
Citigroup
New York
-$963K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$200K +$224K +9,105 New
Bank of America
27
Bank of America
North Carolina
$194K +$162K +6,614 +301%
Truist Financial
28
Truist Financial
North Carolina
$192K -$123 -5 -0.1%
VF
29
Virtu Financial
New York
$186K +$61.6K +2,511 +42%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$159K +$177K +7,224 New
Manulife (Manufacturers Life Insurance)
31
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$155K +$173K +7,067 New
JP Morgan Chase
32
JP Morgan Chase
New York
$154K +$171K +6,977 New
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
$130K -$1.67K -68 -1%
MWM
34
Meridian Wealth Management
Kentucky
$110K +$110K +4,500 +900%
AWP
35
Ascent Wealth Partners
New York
$94K – – –
Principal Financial Group
36
Principal Financial Group
Iowa
$92K +$103K +4,193 New
VOYA Investment Management
37
VOYA Investment Management
Georgia
$92K +$103K +4,204 New
Citadel Advisors
38
Citadel Advisors
Florida
$91K -$171K -6,957 -63%
Commonwealth Equity Services
39
Commonwealth Equity Services
Massachusetts
$83K +$4.17K +170 +5%
UBS Group
40
UBS Group
Switzerland
$64K +$28K +1,139 +64%
Invesco
41
Invesco
Georgia
$63K +$69.9K +2,846 New
ProShare Advisors
42
ProShare Advisors
Maryland
$61K +$67.7K +2,757 New
AIP
43
Almanack Investment Partners
Pennsylvania
$57K -$319 -13 -0.5%
LPL Financial
44
LPL Financial
California
$49K +$1.23K +50 +2%
RC
45
RegentAtlantic Capital
New Jersey
$45K – – –
AB
46
Amalgamated Bank
New York
$44K +$49.3K +2,007 New
Victory Capital Management
47
Victory Capital Management
Texas
$42K +$8.22K +335 +21%
AllianceBernstein
48
AllianceBernstein
Tennessee
$41K +$45.9K +1,870 New
Osaic Holdings
49
Osaic Holdings
Arizona
$38K +$23.3K +950 +127%
ACP
50
Ashfield Capital Partners
California
$37K – – –
1
2
3 4 5

NMTR Hedge Fund Activity: Q2 2021 in Review

99 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q2 2021, worth a combined $81.7M — down 7.8% from $88.6M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NMTR positions and 25 closed out — a net gain of 9 holders — while 31 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $11.9M. The largest seller was OrbiMed, cutting an estimated $21.1M.

  • 99 institutional investors held 9 Meters Biopharma (NMTR) as of Q2 2021, up from 90 in Q1 2021.
  • Funds reported $81.7M of 9 Meters Biopharma stock for Q2 2021, down 7.8% quarter-over-quarter.
  • 34 funds opened new 9 Meters Biopharma positions in Q2 2021 and 25 closed out, a net change of +9 holders.
  • The largest 9 Meters Biopharma buyer in Q2 2021 was BlackRock, an estimated $11.9M added.
  • The largest 9 Meters Biopharma seller in Q2 2021 was OrbiMed, an estimated $21.1M sold.

Based on aggregated 13F filings for Q2 2021.